Sub-Clinical Disease Activity

WEST PALM BEACH, Fla. — Two experts debated the issue of whether subtypes of multiple sclerosis exist, one from Europe and the other from the United States, during the final day of ACTRIMS.

Differentiating patients with inflammatory bowel disease who have lost response to a biologic used to be considered a “gray zone,” according to Sushama Gundlapalli, MD, MS, a board-certified gastroenterologist at Suburban Gastroenterology Ltd. in Naperville, Illinois.